Regenics vs BreezeMeds: Compounded GLP-1 options compared
Regenics vs BreezeMeds: Regenics gives a lower-cost first-month entry for compounded semaglutide and tirzepatide with nurse-practitioner-led telehealth; BreezeMeds lists injectable and oral GLP-1 options starting higher and emphasizes discreet shipping. Early verdict: Regenics is the lower-cost promotional entry for compounded GLP-1s with NP oversight, while BreezeMeds highlights broader formats including oral options and multiple starting prices to confirm.
Price and promotional structure compared
Regenics advertises compounded semaglutide at $139 first month and tirzepatide at $189 first month, with renewals noted at $199 and $279 respectively and a specific note that promotional pricing applies to the first month only. BreezeMeds lists semaglutide injection starting at $199/mo and tirzepatide injection starting at $299, with oral semaglutide and oral tirzepatide displayed from $399. BreezeMeds also shows a separate $169 figure that is not clearly tied to a specific product.
Medications and formats: injectable, oral, compounded
Both providers offer GLP-1 medications, but their presented formats differ. Regenics focuses on compounded semaglutide and compounded tirzepatide plus an optional Sermorelin peptide therapy. BreezeMeds lists injectable semaglutide and tirzepatide and also displays oral semaglutide and oral tirzepatide options. The comparison point to note: Regenics emphasizes compounded products prepared by U.S. licensed compounding pharmacies; BreezeMeds shows both injectable and oral formulations but some pricing lines lack clear product association.
View Regenics medication details
Clinician oversight and regulatory notes
Both sites state treatment is available only when a licensed clinician determines it is medically appropriate. Regenics specifies nurse-practitioner-led GLP-1 care and that licensed nurse practitioners review intake before anything is prescribed. Both providers include the regulatory qualifier that compounded medications, when offered, are not FDA-approved and are not reviewed by FDA for safety, effectiveness or quality. BreezeMeds notes medication-specific approval status must be confirmed and that branded and compounded products are not interchangeable.
Shipping, pharmacy verification, and program features
Regenics advertises free shipping with medication compounded in the USA and a LegitScript certified pharmacy network. BreezeMeds emphasizes discreet home delivery and ongoing support, describing its offering as discreet shipping to your door. BreezeMeds mentions affordability and multiple starting prices but captured evidence shows fees and billing commitments were not fully visible.
Comparison table
| Criterion | Regenics | BreezeMeds |
|---|---|---|
| Starting price (semaglutide) | $139 first month (promotional) | $199/mo listed |
| Starting price (tirzepatide) | $189 first month (promotional) | $299 listed for injection |
| Formats offered | Compounded semaglutide and tirzepatide; Sermorelin peptide | Injectable and oral semaglutide and tirzepatide listed |
| Clinician oversight | Licensed nurse practitioners review intake | Clinician-reviewed online treatment; eligibility subject to live offer |
| Shipping and pharmacy | Free shipping; compounding in USA; LegitScript certified pharmacy network | Discreet home delivery; pricing and state availability to confirm |
| Regulatory note | Compounded meds are not FDA-approved and are not reviewed by FDA for safety, effectiveness or quality | Medication-specific approval status must be confirmed; compounded status requires confirmation |
What stands out in Regenics vs BreezeMeds
Three distinctive differences supported by the sources: price entry point, product formats, and explicit clinician staffing. Regenics stands out for a lower promotional first-month price for compounded GLP-1s and explicit nurse-practitioner-led care plus a Sermorelin add-on. BreezeMeds stands out for listing both injectable and oral GLP-1s and for price lines that require verification, including a $169 figure not clearly tied to a product.
Final comparison and how to choose
Regenics vs BreezeMeds conclusion: If you want a lower-cost promotional first month with compounded semaglutide or tirzepatide and explicit nurse-practitioner oversight, Regenics presents that option and notes renewals are higher. If you need or prefer oral GLP-1 formats or want a provider that displays injectable and oral options, BreezeMeds lists those formats but you should confirm which starting price applies and state availability. Remember that both require a licensed clinician to determine medical appropriateness and that compounded medications are not FDA-approved and are not reviewed by FDA for safety, effectiveness or quality.
Choose Regenics if you want a lower promotional first-month entry price, nurse-practitioner-led telehealth care, and a U.S. compounding network. Choose BreezeMeds if you want injectable and oral GLP-1 options displayed and discreet home delivery but verify pricing, product association, and state availability.